Synapse - Gregory Riely

Results (175)

Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The Memorial Sloan-Kettering experience

Meeting Abstract

Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B. J.; Finley, D.; Azzoli, C. G.; Riely, G. J.; Rusch, V. W.; Kris, M. G.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Pack years of cigarette smoking as a predictor of survival in 2,013 patients with stage IIIb/IV non-small cell lung cancer (NSCLC)

Meeting Abstract

Janjigian, Y. Y.; McDonnell, K.; Kris, M. G.; Shen, R.; Sima, C. S.; Rizvi, N. A.; Riely, G. J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer

Journal Article

Rizvi, N. A.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M. J.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib

Journal Article

Miller, V. A.; Riely, G. J.; Zakowski, M. F.; Li, A. R.; Patel, J. D.; Heelan, R. T.; Kris, M. G.; Sandler, A. B.; Carbone, D. P.; Tsao, A.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

A randomized phase II trial comparing pulsed erlotinib before or after carboplatin and paclitaxel in patients with stage IIIB or IV non-small cell lung cancer

Meeting Abstract

Riely, G. J.; Rudin, C. M.; Kris, M. G.; Senturk, E.; Azzoli, C. G.; Brahmer, J.; Fogle, M.; Ginsberg, M.; Miller, V. A.; Rizvi, N. A.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Smoking history and frequency of somatic KRAS mutations in adenocarcinoma of the lung

Meeting Abstract

Miller, V. A.; Riely, G. J.; Kris, M. G.; Rosenbaum, D.; Marks, J.; Li, A.; Chitale, D.; Nafa, K.; Pao, W.; Ladanyi, M.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G ("acquired resistance") followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)

Meeting Abstract

Riely, G. J.; Kris, M. G.; Schwartz, L. H.; Akhurst, T.; Zhao, B.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Miller, V. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Molecular analysis of NSCLC patients with acquired resistance to gefitinib or erlotinib

Meeting Abstract

Pao, W.; Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC): Results of a prospective phase II trial

Meeting Abstract

Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Ladanyi, M.; Tsao, A. S.; Sandler, A.; Herbst, R.; Kris, M. G.; Johnson, D. H.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas

Journal Article

Pham, D. K.; Kris, M. G.; Riely, G. J.; Sarkaria, I. S.; McDonough, T.; Chuai, S. K.; Venkatraman, E. S.; Miller, V. A.; Ladanyi, M.; Pao, W.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Gregory J Riely

Results (175)

Meeting Abstract

Meeting Abstract

Journal Article

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Journal Article